Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Phenylalanine on Fungal Mycobiota in Healthy Volunteers
NCT06433310Phase 4Recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Weill Cornell Medicine. Primary endpoints: Changes in phenylpropionic acid levels from baseline in subject fecal material at 2 weeks, Change in fungal population levels, specifically gut Candida levels, from baseline in subject fecal material and swabs at 2 weeks and 1 more. Started Oct 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06433310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06433310.